Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95-2

Endocrine-Related Cancer

Volumn 14, Issue 3, 2007, Pages 713-720

  Cong, Li ^a,b   Gasser, Jessica ^a   Zhao, Jessica ^a   Yang, Baofeng ^b   Li, Fanghong ^a   Zhao, Allan Z ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; CYCLIN D1; CYCLIN E; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PROTEIN KINASE B; PROTEIN P42; PROTEIN P44;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; GENOTYPE; GROWTH INHIBITION; HUMAN; HUMAN CELL; OBESITY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADIPONECTIN; APOPTOSIS; CARCINOMA; CELL PROLIFERATION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; OBESITY; RECEPTORS, ADIPONECTIN; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 35949000153     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-07-0065     Document Type: Article

References (38)

1. Akhmedkhanov A, Zeleniuch-Jacquotte A & Toniolo P 2001 Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives. Annals of New York Academy of Sciences 943 296-315.
2. Brakenhielm E, Veitonmaki N, Cao R, Kihara S, Matsuzawa Y, Zhivotovsky B, Funahashi T & Cao Y 2004 Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. PNAS 101 2476-2481.
3. Bub JD, Miyazaki T & Iwamoto Y 2006 Adiponectin as a growth inhibitor in prostate cancer cells. Biochemical and Biophysisical Research Communications 340 1158-1166.
4. Calle EE & Thun MJ 2004 Obesity and cancer. Oncogene 23 6365-6378.
5. Cantley LC & Neel BG 1999 New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. PNAS 96 4240-4245.
6. Chen TC, Hinton DR, Zidovetzki R & Hofman FM 1998 Up-regulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas. Laboratory Investigation 78 165-174.
7. Chen DC, Chung YF, Yeh YT, Chaung HC, Kuo FC, Fu OY, Chen HY, Hou MF & Yuan SS 2006 Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Letters 237 109-114.
8. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, Wang S, Fortier M, Greenberg AS & Obin MS 2005 Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. Journal of Lipid Research 46 2347-2355.
9. Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, Lukanova A, Rinaldi S, Dossus L, Slimani N, Lundin E et al. 2007 Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. Journal of Clinical Endocrinology and Metabolism. 92 255-263.
10. Dal Maso L, Augustin LS, Karalis A, Talamini R, Franceschi S, Trichopoulos D, Mantzoros CS & La Vecchia C 2004 Circulating adiponectin and endometrial cancer risk. Journal of Clinical Endocrinology and Metabolism. 89 1160-1163.
11. Dieudonne MN, Bussiere M, Dos Santos E, Leneveu MC, Giudicelli Y & Pecquery R 2006 Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochemical and Biophysisical Research Communications 345 271-279.
12. Dougherty DC & Sanders MM 2005 Estrogen action: revitalization of the chick oviduct model. Trends in Endocrinology and Metabolism 16 414-419.
13. Housa D, Housova J, Vernerova Z & Haluzik M 2006 Adipocytokines and cancer. Physiological Research 55 233-244.
14. Indolfi C, Avvedimento EV, Di Lorenzo E, Esposito G, Rapacciuolo A, Giuliano P, Grieco D, Cavuto L, Stingone AM, Ciullo I et al. 1997 Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury. Nature Medicine 3 775-779.
15. Jiang X, Li J, Paskind M & Epstein PM 1996 Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells. PNAS 93 11236-11241.
16. Johnson GL & Lapadat R 2002 Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298 1911-1912.
17. Kadowaki T & Yamauchi T 2005 Adiponectin and adiponectin receptors. Endocrine Reviews 26 439-451.
18. Kahn BB & Flier JS 2000 Obesity and insulin resistance. Journal of Clinical Investigations 106 473-481.
19. Korner A, Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Williams CJ, Kaprara A, Bullen J, Neuwirth A, Tseleni S & Mitsiades N 2007 Total and high molecular weight adiponectin in breast cancer: in vitro and in vivo studies. Journal of Clinical Endocrinology 92 1041-1048.
20. Laviola L, Natalicchio A & Giorgino F 2007 The igf-I signaling pathway. Current Pharmaceutical Design 13 663-669.
21. Luo Z, Saha AK, Xiang X & Ruderman NB 2005 AMPK, the metabolic syndrome and cancer. Trends in Pharmacological Sciences 26 69-76.
22. Murray AW 2004 Recycling the cell cycle: cyclins revisited. Cell 116 221-234.
23. Nikaido T, Li SF, Shiozawa T & Fujii S 1996 Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas. Cancer 78 1248-1253.
24. Oshita T, Shigemasa K, Nagai N & Ohama K 2002 p27, Cyclin E, and CDK2 expression in normal and cancerous endometrium. International Journal Oncology 21 737-743.
25. Otake S, Takeda H, Suzuki Y, Fukui T, Watanabe S, Ishihama K, Saito T, Togashi H, Nakamura T, Matsuzawa Y et al. 2005 Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clinical Cancer Research 11 3642-3646.
26. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M et al. 2000 Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102 1296-1301.
27. Petridou E, Mantzoros C, Dessypris N, Koukoulomatis P, Addy C, Voulgaris Z, Chrousos G & Trichopoulos D 2003 Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. Journal of Clinical Endocrinology and Metabolism. 88 993-997.
28. Rattan R, Giri S, Singh AK & Singh I 2005 5-Aminoimidazole-4- carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase. Journal of Biological Chemistry 280 39582-39593.
29. Reynolds RK, Hu C & Baker VV 1998 Transforming growth factor-alpha and insulin-like growth factor-I, but not epidermal growth factor, elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines. Gynecologic Oncology 70 202-209.
30. Ronchi CL, Corbetta S, Cappiello V, Morpurgo PS, Giavoli C, Beck-Peccoz P, Arosio M & Spada A 2004 Circulating adiponectin levels and cardiovascular risk factors in acromegalic patients. European Journal of Endocrinology 150 663-669.
31. Scherer PE, Williams S, Fogliano M, Baldini G & Lodish HF 1995 A novel serum protein similar to C1q, produced exclusively in adipocytes. Journal of Biological Chemistry 270 26746-26749.
32. Tashiro H, Blazes MS, Wu R, Cho KR, Bose S, Wang SI, Li J, Parsons R & Ellenson LH 1997 Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Research 57 3935-3940.
33. Toker A & Yoeli-Lerner M 2006 Akt signaling and cancer: surviving but not moving on. Cancer Research 66 3963-3966.
34. Wang Y, Lam JB, Lam KS, Liu J, Lam MC, Hoo RL, Wu D, Cooper GJ & Xu A 2006 Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Research 66 11462-11470.
35. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE & Tataranni PA 2001 Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism. 86 1930-1935.
36. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K et al. 2002 Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine 8 1288-1295.
37. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M et al. 2003 Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423 762-769.
38. Zhu X, Kwon CH, Schlosshauer PW, Ellenson LH & Baker SJ 2001 PTEN induces G(1) cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells. Cancer Research 61 4569-4575.